Category: age-related macular degeneration

We are excited to offer our patients a new treatment for wet age-related macular degeneration (AMD). Last month, the FDA approved Beovu® (brolucizumab) which is a new anti-vascular endothelial growth factor (anti-VEGF) antibody that may require few injections than the existing medications already on the market. This is the first new drug approved since 2011… Read More

Welcome to February.  The new month may mean different things for different people.  For all the sports fanatics, the first Sunday of the month means the Super Bowl!  The New England Patriots are in the finals again.  In Super Bowl 53, Tom Brady is facing off against the young Ram Jared Goff in Atlanta. Or,… Read More